SEC Form 4 · accession 0001209191-16-126167
Arbutus Biopharma Corp · ABUS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vivek Ramaswamy
Director · 10% Owner
Period of report
Jun 3, 2016
Accepted (ET)
Jun 7, 2016 · 1:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001447028
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $3.99 | Jun 3, 2016 | A | 7,500 | A | — | Jun 2, 2026 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1The shares underlying this option fully vested on June 3, 2016.